McDermott Will & Emery advised Abenex and other shareholders of Ekoscan Integrity, a French manufacturer of ultrasonic non-destructive testing equipment, in connection with the acquisition of an equity interest by Eurazeo through its small-mid buyout team.

McDermott also advised the founder of Ekoscan Integrity, Mr. Hugo Cence, in his reinvestment alongside Eurazeo, Fonds France Nucléaire 2, managed by Siparex, and ALIAD (Air Liquide Venture Capital), the current institutional shareholder of Ekoscan Integrity, which is also reinvesting.

This operation is aimed at pursuing the international development of the group.

The McDermott team involved in this operation was composed of:

Corporate

• Grégoire Andrieux, partner
• Julien-Pierre Tannoury, associate
• Marie-Lou Pichoux, associate

Tax

• Côme de Saint-Vincent, partner

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

McDermott Will & Emery advised Otium Partners and Archipel Group on the creation and regulatory structuring of Archipel Group, a €50 million equity fundraising from Otium Capital and the acquisition of the Rey Group. The ambition of the Archipel Group is to become a leading group in accounting expertise, by federating autonomous firms.

The McDermott team involved in this operation was composed of:

Corporate

• Guillaume Kellner, partner
• Stanislas Offroy, counsel
• Auriane Tournay, associate

Regulatory

• Laurent Ayache, partner
• Charlotte Michellet, partner

Tax

• Antoine Vergnat, partner
• Côme de Saint-Vincent, partner
• Hugo Jentile, associate

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

McDermott Will & Emery has advised Cryoport, a global provider of supply chain solutions to the biopharmaceutical, reproductive medicine and animal health markets, on the sale to DHL Group of CRYOPDP, a leading provider of transportation solutions specializing in logistics for clinical trials, biopharmaceuticals and cell and gene therapies.

In conjunction with this sale, Cryoport and DHL announced a strategic partnership to strengthen their supply chain solutions offerings to the global life sciences and health care industry.

The transaction is subject to regulatory approval.

This cross-border transaction mobilized the following McDermott teams:

Paris Corporate

• Bertrand Delafaye, Partner
• Come Wirz, Counsel
• Auriane Tournay, Associate
• Ruben Johannsen, Juriste

Paris Tax

• Antoine Vergnat, Partner
• Louisiana Lungu, Associate

Paris Regulatory

• Sabine Nauges, Partner
• Paul Tisseyre, Associate

Paris Antitrust

• Frédéric Pradelles, Partner
• Mary Hecht, Associate

Paris Social

• Abdel Abdellah, Counsel
• Charlotte Biscotti, Associate

US Tax

• Michael J. Bruno, Partner
• Andrew M. Granek, Partner

Germany Tax

• Marcus Fischer, Counsel

UK Regulatory

• Raminta Dereskeviciute, Partner

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.